SU1217248A3 - Способ получени производных 4-/2-окси-4-замещенных/ фенилнафталин-2-олов - Google Patents

Способ получени производных 4-/2-окси-4-замещенных/ фенилнафталин-2-олов Download PDF

Info

Publication number
SU1217248A3
SU1217248A3 SU813336984A SU3336984A SU1217248A3 SU 1217248 A3 SU1217248 A3 SU 1217248A3 SU 813336984 A SU813336984 A SU 813336984A SU 3336984 A SU3336984 A SU 3336984A SU 1217248 A3 SU1217248 A3 SU 1217248A3
Authority
SU
USSR - Soviet Union
Prior art keywords
carbon atoms
alk
hydrogen
aryl
spectrogram
Prior art date
Application number
SU813336984A
Other languages
English (en)
Russian (ru)
Inventor
Росс Джонсон Майкл
Шерман Мелвин Лоренс (младший)
Original Assignee
Пфейзер Инк (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфейзер Инк (Фирма) filed Critical Пфейзер Инк (Фирма)
Application granted granted Critical
Publication of SU1217248A3 publication Critical patent/SU1217248A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/42—Halogenated derivatives containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/196—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/38—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SU813336984A 1980-09-19 1981-09-18 Способ получени производных 4-/2-окси-4-замещенных/ фенилнафталин-2-олов SU1217248A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/189,402 US4285867A (en) 1980-09-19 1980-09-19 Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor

Publications (1)

Publication Number Publication Date
SU1217248A3 true SU1217248A3 (ru) 1986-03-07

Family

ID=22697189

Family Applications (2)

Application Number Title Priority Date Filing Date
SU813336984A SU1217248A3 (ru) 1980-09-19 1981-09-18 Способ получени производных 4-/2-окси-4-замещенных/ фенилнафталин-2-олов
SU823508959A SU1217249A3 (ru) 1980-09-19 1982-11-04 Способ получени транс-4а-5,8,8а-татрагидронафталин-2 ( @ ),6 (7 @ )-дион-6-этиленкетал

Family Applications After (1)

Application Number Title Priority Date Filing Date
SU823508959A SU1217249A3 (ru) 1980-09-19 1982-11-04 Способ получени транс-4а-5,8,8а-татрагидронафталин-2 ( @ ),6 (7 @ )-дион-6-этиленкетал

Country Status (27)

Country Link
US (1) US4285867A (enExample)
EP (1) EP0049953B1 (enExample)
JP (1) JPS57112344A (enExample)
KR (1) KR850001337B1 (enExample)
AR (1) AR228617A1 (enExample)
AT (1) ATE7487T1 (enExample)
AU (1) AU526673B2 (enExample)
CA (2) CA1166639A (enExample)
CS (4) CS221989B2 (enExample)
DD (2) DD206986A5 (enExample)
DE (1) DE3163651D1 (enExample)
DK (1) DK415281A (enExample)
ES (2) ES8301872A1 (enExample)
FI (1) FI75143C (enExample)
GR (1) GR75346B (enExample)
HU (1) HU191337B (enExample)
IE (1) IE51630B1 (enExample)
IL (1) IL63869A (enExample)
IN (1) IN157167B (enExample)
NO (2) NO813186L (enExample)
NZ (2) NZ198390A (enExample)
PH (1) PH17616A (enExample)
PL (5) PL131787B1 (enExample)
PT (1) PT73700B (enExample)
SU (2) SU1217248A3 (enExample)
YU (2) YU225981A (enExample)
ZA (1) ZA816489B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593131A (en) * 1980-09-19 1986-06-03 Pfizer Inc. Pharmacologically active 4-[2-hydroxy-4-(substituted)phenyl]naphthalen-2(1H)-ones and 2-ols, derivatives thereof and intermediates therefor
US4360700A (en) * 1981-11-02 1982-11-23 Pfizer Inc. Intermediates for making 1-(3-benzyloxyphenyl)-1,1-dimethylheptane
JP4639414B2 (ja) * 1998-12-25 2011-02-23 Ｄｉｃ株式会社 デカヒドロナフタレン誘導体及びその製造方法
CN107915633A (zh) * 2017-12-06 2018-04-17 安徽绩溪县徽煌化工有限公司 一种间苄氧基苯甲酸甲酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB464328A (en) * 1935-10-09 1937-04-09 Henkel & Cie Gmbh Improvements in or relating to the manufacture of hydroarylated aromatic hydroxy compounds and derivatives thereof
US2993056A (en) * 1956-08-31 1961-07-18 Istituto Sieroterapico Italian Production of the 1-6-lactone of 6-hydroxy-8-acetoxy-octanoic acid
US2886589A (en) * 1957-08-05 1959-05-12 Merck & Co Inc 8-methyl-5-oxyphenyl hexahydroindan compounds
US3862986A (en) * 1966-07-01 1975-01-28 Hoffmann La Roche 1-Hydroxymethyl-amino-2-alkyl-or allyl-2-(3{40 -methoxy-phenyl)-chclohexanes
US3576887A (en) * 1967-05-01 1971-04-27 American Home Prod Process for the preparation of oxaphenanthrenes and intermediates therefor
US3378589A (en) * 1967-05-01 1968-04-16 American Cyanamid Co Process of preparing the ring b carbon analog of griseofulvin
US3974157A (en) * 1974-03-04 1976-08-10 Pennwalt Corporation 1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters
US4283569A (en) * 1977-09-13 1981-08-11 Pfizer Inc. Hydroxyalkyl and oxoalkyl substituted phenols as analgesics and sedatives
PL122765B1 (en) 1977-09-13 1982-08-31 Method of manufacture of novel derivatives of cycloalkanes
SE431085B (sv) * 1977-09-13 1984-01-16 Pfizer 3-(2-hydroxi-4-(substituerade)fenyl)cykloalkanoner och -cykloalkanoder och vissa derivat derav till anvendning for farmakologiska och medicinska endamal
US4188495A (en) * 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Патент US № 3974157, кл. 260-247.2, опублик. 1970. Мащковский Д.М. Лекарственные средства. Т. 1, 1977, с. 160-161, 147. . *

Also Published As

Publication number Publication date
PL237441A1 (en) 1983-02-14
PL237442A1 (en) 1983-02-14
EP0049953A3 (en) 1982-12-08
YU149283A (en) 1983-12-31
PL233104A1 (enExample) 1982-11-08
ZA816489B (en) 1982-09-29
DD206986A5 (de) 1984-02-15
KR850001337B1 (ko) 1985-09-19
DK415281A (da) 1982-03-20
PL135169B1 (en) 1985-10-31
CA1171416A (en) 1984-07-24
IL63869A0 (en) 1981-12-31
SU1217249A3 (ru) 1986-03-07
PH17616A (en) 1984-10-05
CS221990B2 (en) 1983-04-29
FI75143B (fi) 1988-01-29
IL63869A (en) 1985-03-31
ES8306087A1 (es) 1983-05-01
IE51630B1 (en) 1987-01-21
NO813186L (no) 1982-03-22
PT73700B (en) 1983-10-19
KR830007592A (ko) 1983-11-04
PL131787B1 (en) 1985-01-31
AR228617A1 (es) 1983-03-30
PL138052B1 (en) 1986-08-30
CS221988B2 (en) 1983-04-29
CA1166639A (en) 1984-05-01
AU526673B2 (en) 1983-01-27
JPS6158456B2 (enExample) 1986-12-11
YU225981A (en) 1984-02-29
EP0049953B1 (en) 1984-05-16
FI812927L (fi) 1982-03-20
NO823160L (no) 1982-03-22
JPS57112344A (en) 1982-07-13
IE812185L (en) 1982-03-19
EP0049953A2 (en) 1982-04-21
DE3163651D1 (en) 1984-06-20
ES505625A0 (es) 1982-12-16
CS221989B2 (en) 1983-04-29
PL237443A1 (en) 1983-02-14
PT73700A (en) 1981-10-01
PL134880B1 (en) 1985-09-30
ES8301872A1 (es) 1982-12-16
CS221991B2 (en) 1983-04-29
PL133727B1 (en) 1985-06-29
NZ206872A (en) 1984-12-14
US4285867A (en) 1981-08-25
IN157167B (enExample) 1986-02-01
NZ198390A (en) 1984-12-14
FI75143C (fi) 1988-05-09
HU191337B (en) 1987-02-27
ATE7487T1 (de) 1984-06-15
GR75346B (enExample) 1984-07-13
ES514376A0 (es) 1983-05-01
AU7547481A (en) 1982-06-10
DD209434A5 (de) 1984-05-09

Similar Documents

Publication Publication Date Title
TWI451870B (zh) 脂肪酸醯胺水解酶抑制劑
US5847128A (en) Water soluble derivatives of cannabinoids
JPS6033834B2 (ja) ヘキサヒドロジベンゾピラノン類の製法
DD204698A5 (de) Verfahren zur herstellung von 3,4-dihydro-5h-2,3-benzodiazepin derivaten
JPS5892611A (ja) 抗繊維素溶解活性化合物及び抗繊維素溶解剤並びに抗繊維素溶解活性化合物の製造方法
US4599355A (en) Treatment of sleep disorders
CH683427A5 (fr) Composé d'isoquinoléine comme agents de blocage neuromusculaire.
JPH05503077A (ja) 抗腫瘍剤としてのイルージンアナログ
JPS5838263A (ja) ピリダジン誘導体
DD210687A5 (de) Verfahren zur herstellung von (+)-cyanidan-3-ol-derivaten
WO1990008539A1 (en) Myo-inositol analogs and methods for their use
SU1316563A3 (ru) Способ получени бициклических бензоконденсированных соединений
US4315862A (en) Process for preparing cannabichromene
EP0038343A1 (de) Substituierte oxocarbonsäuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel.
JP2019531353A (ja) 重水素化化合物及びその医薬的用途
US3248292A (en) Pharmaceutically active dimethoxyquinazolines
JPS60136580A (ja) （５−フエニル−１，３−ジオキサン−４−イル）アルケノイツク酸又はアルカノイツク酸誘導体、その製造法及び該化合物を含有する医薬品
FI77840C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara resorcinderivat.
EP0238883A1 (en) Oxabicycloheptane derivatives, pharmaceutical composition and use
JPH06122623A (ja) 抗腫瘍剤
KR940009791B1 (ko) 퀴누클리딘 유도체의 제조방법
EP0215319A2 (en) Gem-dihalo-1,8-diamino-4-aza-octanes
EP1507523A1 (en) Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
CA1089867A (fr) Derives du benzofuranne
EP0143711A2 (fr) Dérivés de N-(méthoxyphénacyl)-amine, utilisation notamment en thérapeutique et procédé de préparation